Viewing Study NCT01462695


Ignite Creation Date: 2025-12-24 @ 1:36 PM
Ignite Modification Date: 2026-01-07 @ 11:43 AM
Study NCT ID: NCT01462695
Status: COMPLETED
Last Update Posted: 2015-08-27
First Post: 2011-10-27
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
Sponsor: National Cancer Institute (NCI)
Organization: